Improvement of Total Knee Arthroplasty Effectiveness Through Preoperative Correction of Clinical and Functional Disorders Using a Multimodal Phenotype-Based Prehabilitation Approach
| Registry | NCT07790146, acronym TKA-PREHAB |
|---|---|
| Status | Completed |
| Phase | Not applicable |
| Study type | Interventional; randomized, parallel, masking: none, treatment |
| Enrollment | 64 (Actual) |
| Sponsor | Samara State Medical University (Other) |
| Conditions | Knee Osteoarthritis, Total Knee Arthroplasty |
| Interventions | Multimodal phenotype-based prehabilitation (Procedure) |
| Dates | start 2023-01-01, primary completion 2025-12-31, completion 2025-12-31, first posted 2026-08-27, last updated 2026-10-15 |
| Locations | 1 site in Russia |
Related Papers Related Patents Related Grants Related Experts
AI Assistant Save
All trials for Knee Osteoarthritis All trials for Total Knee Arthroplasty All trials of Multimodal phenotype-based prehabilitation
Total knee arthroplasty (TKA) is the most effective treatment for stage III-IV knee osteoarthritis (OA). However, up to 30% of patients remain dissatisfied due to periarticular functional insufficiency, pain, and movement limitations. This study aims to improve TKA outcomes by developing and implementing a multimodal prehabilitation approach based on OA phenotypes (chronic pain, inflammatory, biomechanical) to correct clinical and functional disorders preoperatively, thereby enhancing postoperative recovery and quality of life.
Objectives:
1. To develop and implement a multimodal prehabilitation approach for patients undergoing TKA.
2. To create a computer program for selecting an individual prehabilitation complex based on the identified OA phenotype.
3. To compare TKA outcomes in patients with and without the prehabilitation complex.
4. To evaluate the effectiveness of the prehabilitation approach using a dedicated computer program.
5. To improve the algorithm of medical care organization for patients undergoing TKA.
Study Material:
A total of 64 patients with knee OA stage III-IV (Kellgren-Lawrence classification) were included. Patients were randomized into two groups: the main group (n=31) receiving the prehabilitation complex, and the control group (n=33) receiving standard preoperative care.
Study Design: Single-center, prospective, open-label, randomized, controlled interventional clinical study.
Inclusion Criteria:
* Age 18 to 70 years
* Verified knee OA stage III-IV (Kellgren-Lawrence)
* Intermalleolar distance ≤ 8 cm (valgus) or intercondylar distance ≤ 8 cm (varus)
* Limb shortening ≤ 2 cm
* BMI < 35 kg/m²
* Barthel Index > 65 points
* No decompensation of concomitant chronic diseases
* No recent physiotherapy or intra-articular injections (within 1-3 months)
* Signed informed consent
Exclusion Criteria:
* Age < 18 or > 70 years
* Limb shortening > 2 cm
* Previous knee surgery or trauma indicating secondary OA
* BMI ≥ 35 kg/m²
* Decompensated chronic infectious or non-infectious diseases
* Inability to comply with the follow-up schedule
Methods:
Clinical and functional assessment was performed 4 weeks and 72 hours before surgery, and 72 hours, 4 weeks, and 12 weeks after surgery. Assessment tools included WOMAC, KOOS, VAS, HSS-KRES questionnaires, surface electromyography (EMG) of thigh and calf muscles, Two Minute Walking Test (2MWT), and Timed Up and Go (TUG) test. Statistical analysis was performed using IBM SPSS Statistics 25.
Scientific Novelty:
A new multimodal prehabilitation approach based on OA phenotyping was developed and patented (RF Patent No. 2844621). Two computer programs were created: one for determining the individual prehabilitation complex (RF Software Certificate No. 2026610177) and another for evaluating prehabilitation results (RF Software Certificate No. 2025662976).
Expected Results:
The prehabilitation complex is expected to increase the rate of favorable clinical outcomes by 2.13 times at 12 weeks post-TKA, with significant improvements in WOMAC, VAS, EMG parameters, and 2MWT distance compared to the control group.
| Arm | Type | Interventions | Description |
|---|---|---|---|
| Main group (prehabilitation) | Experimental | Procedure: Multimodal phenotype-based prehabilitation | Patients (n=31) receiving a 4-week multimodal prehabilitation complex prior to TKA, tailored to their specific OA phenotype (chronic pain, inflammatory, or biomechanical). The complex includes mechanotherapy, breathing exercises, psychological support, kinesiotaping, and phenotype-specific physiotherapy (SMT, magnetotherapy, or robotic mechanotherapy). |
| Control group (standard care) | No intervention | Patients (n=33) receiving standard preoperative examination and routine care without a structured, phenotype-based prehabilitation complex prior to TKA. |
Sex: All, ages: 18 Years to 70 Years
Inclusion Criteria: * Age 18 to 70 years * Verified knee OA stage III-IV (Kellgren-Lawrence) * Intermalleolar distance ≤ 8 cm (valgus) or intercondylar distance ≤ 8 cm (varus) * Limb shortening ≤ 2 cm * BMI < 35 kg/m² * Barthel Index > 65 points * No decompensation of concomitant chronic diseases * No recent physiotherapy or intra-articular injections (within 1-3 months) * Signed informed consent Exclusion Criteria: * Age < 18 or > 70 years * Limb shortening > 2 cm * Previous knee surgery or trauma indicating secondary OA * BMI ≥ 35 kg/m² * Decompensated chronic infectious or non-infectious diseases * Inability to comply with the follow-up schedule
| Facility | City | Country | Status |
|---|---|---|---|
| Clinics of Samara State Medical University, Department of Traumatology and Orthopedics | Samara, Samara Oblast | Russia |